Zogenix Inc. (ZGNX)
NASDAQ: ZGNX
· Real-Time Price · USD
26.68
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Zogenix Revenue Breakdown
| Period Ending | Dec 31, 2014 |
|---|---|
| Zohydro ER Revenue | 5M |
| Zohydro ER Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 43.81M | 39.56M | 33.88M | 31.27M | 18.89M | 26.55M | 24.43M | 21.32M | 18.65M | 15.76M | 15.46M | 10.92M | 11.29M | 11.02M | 8.58M | 8.07M | 7.76M | 6.07M | 5.5M | 6.55M | 7.49M | 6.54M | 6.84M | 6.12M | 6.8M | 5.7M | 7.58M | 6.27M |
| Selling, General, and Administrative Revenue Growth | +10.75% | +16.75% | +8.35% | +65.55% | -28.86% | +8.69% | +14.60% | +14.29% | +18.34% | +1.96% | +41.59% | -3.27% | +2.46% | +28.44% | +6.28% | +4.05% | +27.71% | +10.38% | -16.05% | -12.50% | +14.56% | -4.47% | +11.76% | -9.94% | +19.38% | -24.87% | +20.96% | n/a |
| Research and Development Revenue | 41.79M | 33.26M | 36.64M | 30.97M | 35.96M | 34.42M | 34.37M | 33.24M | 35.82M | 28.37M | 27.1M | 24.35M | 23.6M | 27.61M | 26.74M | 22.98M | 18.08M | 21.18M | 14.85M | 13.34M | 13.39M | 10.08M | 10.38M | 7.99M | 8.55M | 7.92M | 6.24M | 5.15M |
| Research and Development Revenue Growth | +25.67% | -9.25% | +18.32% | -13.89% | +4.47% | +0.15% | +3.41% | -7.20% | +26.25% | +4.71% | +11.27% | +3.20% | -14.53% | +3.24% | +16.37% | +27.10% | -14.63% | +42.61% | +11.31% | -0.39% | +32.92% | -2.97% | +30.01% | -6.58% | +7.97% | +26.89% | +21.18% | n/a |